Rubicon Organics Stock (TSXV: ROMJ) (OTCQX: ROMJF) - Investor Dashboard

Rubicon Organics
Market Focus: Canada
Classification: Producer
Country: Canada
Employees: 76 as of July, 2020
Established: 2015
CEO: Jesse McConnell


Fiscal Year-End: December
Exchanges: TSXV, OTC
Auditor: Deloitte
Trading Debut: 10/10/18
Headquarters: Vancouver, BC

Financials (03/31/21)

Cash on hand: C$20.2 million
Fixed Investment: C$23.1 million
Shareholders’ Equity: C$46.3 million
Revenues : C$4.1 million
Adj. Gross Margin : -14.4%
EPS : -C$0.08

Capital Structure (05/17/20)

Last Financing: 6.05 million units at C$3.80
Basic Shares: 55.5 million
Warrants: 10.7 million
Options: 4.3 million
Diluted Shares: 73.2 million


Company Brief

Rubicon Organics is leveraging its unique cultivation IP to grow superior quality organic, sustainable, terpene rich flower. The company has substantial CPG innovation expertise to design and bring high margin premium products and brands to market. The company is certified organic by Fraser Valley Organic Producers Association.

Focused on achieving industry leading profitability through a focus on innovation and the development of brands and cannabis 2.0 products. Rubicon Organics flagship products include its super-premium brand Simply Bare™ Organic and its super-premium concentrate brand LAB THEORY™.

Winning premium, the most profitable segment

Interview with CEO Jesse McConnell


  • Anchored on Global CPG Expertise
  • Projecting positive EBITDA by Q2 2021
  • Perfect size production facility to excel in the current market Rubicon’s 125,000 sq. ft. greenhouse is fully planted; 11,000-kilogram annual production capacity
  • Tight alignment, founders and management hold 49% of common shares outstanding
  • Brand portfolio including Simply Bare Organic, Lab Theory, 1964 Supply Co. and Wildflower
  • 90% coverage of the addressable Canadian market

Growth Strategy

  • Continue to take share in premium and super-premium market segments
  • Completion of EU-GMP Certification and first export expected in Q3 2021
  • Multi-year product supply agreement in place with Canacur GmbH, a German cannabis distributor
  • Innovation pipeline in the works for new strains and cannabis 2.0 products


  • 1 of only 6 organic-certified LPs in Canada
  • Differentiated premium offering of super-premium and organic certified cannabis is rare
  • Proven ability to execute: Rubicon’s Founder and CEO also co-founded Whistler Medical Marijuana Corp., which was acquired by Aurora for $175 million
  • Eight provinces and territories selling Rubicon products
  • Rubicon has one of the lowest break-even sales volumes compared to its peers
  • Focuses on growing a sustainable business and releases an ESG Report to communicate its progress

Institutional Analyst Coverage

Greg McLeish
Mackie Research

John Chu

Neil Gilmer

Rahul Sarugaser
Raymond James

Curated Stories & News

Visit Rubicon Organics.

New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. Rubicon Organics, Inc. is a client of NCV Media, LLC. Read our full disclaimer.